跳至主要内容
临床试验/JPRN-UMIN000013242
JPRN-UMIN000013242招募中2 期

Phase II trial of palliative intra-arterial epirubicin/5FU therapy for patients with chemotherapy-refractory locally-advanced or metastatic breast cancer - JIVROSG-1107(RESAIC-II)

Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 个研究点目标入组 30 人开始时间: 2014年2月24日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • a)History of non-breast malignancies within the 5 years prior to study entry b)Symptomatic breast metastasis c)Concurrent serious diseases that may interfere with planned treatment d) Stenosis of subclavian artery by contrast-enhanced CT e) bilateral breast cancer or multiple lesions within the region f) Pregnant or lactating women g) Patient unfeasible for ambulatory chemotherapy

研究者

发起方
Japan Interventional Radiology in Oncology Study Group (JIVROSG)

相似试验